More Blues agree to pay for prescription digital therapeutics
"It's been tough sledding in terms of formulary coverage of these products," said Alex Kilgore, a life sciences analyst at Xcenda, a consulting arm of the pharmaceutical wholesaler AmerisourceBergen. "But there's been a lot of momentum with Highmark's decision and state Medicaid policies. We're seeing more digital therapeutics get coverage for reimbursement."
For the full article, please visit Modern Healthcare.